Cano Health, Inc.
CANOQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -315.95% | -186.78% | -892.03% | -1,263.41% | -18,847.19% |
| Total Depreciation and Amortization | -1.61% | 17.03% | 29.83% | 42.56% | 57.79% |
| Total Amortization of Deferred Charges | 3.36% | 29.33% | 42.88% | 331.09% | 21.07% |
| Total Other Non-Cash Items | 438.86% | 19.60% | 321.85% | 132.00% | 147.15% |
| Change in Net Operating Assets | 462.41% | 300.49% | 345.78% | 255.23% | -123.20% |
| Cash from Operations | -7.07% | 11.81% | -36.35% | 23.21% | 1.38% |
| Capital Expenditure | 68.04% | 61.17% | 43.01% | 14.21% | -18.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 91.85% | 99.83% | 99.79% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 456.18% | 441.96% | 440.45% | -76.39% | 51.26% |
| Cash from Investing | 140.39% | 117.09% | 89.25% | 89.78% | 94.70% |
| Total Debt Issued | 38.32% | 256.58% | 1,359.21% | -51.47% | -75.35% |
| Total Debt Repaid | 9.73% | -520.50% | -533.86% | 36.24% | 79.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 81.32% | 81.32% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.99% | -9,186.36% | -173.09% | -11.63% | -101.06% |
| Cash from Financing | 96.95% | 123.07% | 1,720.78% | -63.24% | -90.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 295.27% | 135.65% | 109.32% | 92.59% | -164.03% |
